Navigation Links
SNM applauds FDA's decision to approve Zevalin
Date:9/10/2009

RESTON, Va.SNM applauds the U.S. Food and Drug Administration's (FDA) recent decision to approve the radioimmunotherapy (RIT) drug, Zevalin, as a front-line treatment of non-Hodgkin's lymphoma (NHL).

"This is welcome news for patients with non-Hodgkin's lymphoma," said Michael M. Graham, M.D., Ph.D., president of SNM and director of nuclear medicine at the University of Iowa Carver College of Medicine. "We've known for some time that RIT works extremely well for many NHL patients. With the FDA's approval, more patients can take advantage of this promising treatment sooner rather than later, giving them more hope for a brighter future."

This is the first time that the drug has been approved as an effective treatment option at the time of onset of lymphoma. Previously, Zevalin was approved only to treat lymphoma after a relapse, or after all conventional therapies failed. Now, patients with NHL can reap the same benefits earlier on in the disease, before it progresses to a more serious stage.

Non-Hodgkin's lymphomaone of the two main types of lymphomahas many different forms and is the fifth most common cancer in the United States. When lymphoma is first diagnosed, treatment choices depend on the cell type, extent of disease and rate of progression. New and emerging molecular imaging therapies, such as RIT, continue to provide major breakthroughs for patients with NHL by allowing tailored treatments at the molecular level. RIT is a more highly targeted therapy than traditional treatments because molecular imaging techniques and therapies can pinpoint the exact location of disease and deliver a tumor-killing dose of a radioactive substance directly to the cancer cells while sparing healthy cells.

"New developments in molecular imaging technologies are dramatically improving the ways in which lymphoma is diagnosed and treated," says Peter S. Conti, M.D., Ph.D., professor of radiology, clinical pharmacy and biomedical engineerin
'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. National Alliance for Hispanic Health Applauds President Obamas Efforts to Achieve Meaningful Health Care Reform in 2009
2. The American Heart Association Applauds Recommendations in New Childhood Obesity Report
3. HIMSS Electronic Health Record Association Applauds Federal Support of EHR Implementation for Hospitals and Physician Practices
4. NABP Applauds LegitScript and KnujOn for Spotlighting Exploitation of Internet Ad Programs by Rogue Internet Drug Outlets
5. Americans United for Life Applauds Decision Protecting Women From Dangers of RU-486
6. The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs
7. National Alliance for Hispanic Health Applauds Confirmation of Sonia Sotomayor as the Nations 111th Supreme Court Justice
8. The Scleroderma Foundation Applauds Introduction of First Bill in the Senate Promoting Research and Awareness of Scleroderma
9. GMA Applauds U.S. House for Passage of Landmark Food Safety Bill
10. Partnership Applauds Obamas No Cost-Sharing Protections for Preventive Services
11. APHA Applauds Congressional Action on Health Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College ... as the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who has ... the college expand its reach and impact through innovative technologies and strategies. , “I ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... On Saturday, ... Mesothelioma Applied Research Foundation (Meso Foundation) will present an educational program titled ... 7:00 PM and lasts through 9:30 PM (doors open at 6:45pm) at Calvary United ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... may extend and improve the lives of patients, according to a newly published ... here to read the full article. , The authors of the new ...
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor ... (which astronomically, officially ends on September 22nd this year). For IT security personnel, it ... linger on which could prove far more costly than a simple headache. , Joe ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain have ... soft tissue manipulation. Platelet rich plasma injections also have mixed results. Building ... treatment outcomes. This localized treatment seems to address the symptoms and does ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... ANGELES (May 5, 2010) High doses of antioxidant ... genetic abnormalities in cells, which may predispose supplement-takers to developing ... Institute. The study, led by Eduardo Marbn, ... online today in the medical journal Stem Cells . ...
... ... launches their professional organization business specializing in all areas of the home. ... (PRWEB) ... market this month. The company’s mission is to create fabulous homes through ...
... stroke , TUESDAY, May 4 (HealthDay News) -- Being ... attack or stroke in men older than 45, a new ... ages 45 to 69, who enrolled in the California Men,s ... followed until Dec. 31, 2007. , During the follow-up, there ...
... experts say , TUESDAY, May 4 (HealthDay News) -- While rates ... the United States, a new study finds that among young, white ... of lower stomach cancer is infection with the bacteria Helicobacter ... by acid reflux. Most stomach cancers are found in those aged ...
... works in different fashion than the current widely accepted ... of the drugparticularly in people with cancer and diseases ... (LAM). The results of this study, led ... Diseases Institute, are published in the May 5 edition ...
... A medication most often used to treat heart arrhythmias also ... type of muscular dystrophy in adults. The findings about ... were published May 4 in the journal Neurology , ... there is no drug approved to treat myotonic dystrophy, an ...
Cached Medicine News:Health News:High doses of antioxidant supplements induce stem cell genetic abnormalities 2Health News:Stomach Cancer on the Rise Among Young, White Adults 2Health News:Stomach Cancer on the Rise Among Young, White Adults 3Health News:Popular diabetes drug works differently than thought 2Health News:Heart drug effective for treating symptom of muscular dystrophy 2Health News:Heart drug effective for treating symptom of muscular dystrophy 3
(Date:8/28/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 28, 2015 ... therapeutics for the treatment of cancer, today announced the ... the U.S. Securities and Exchange Commission (SEC) relating to ... The number of shares to be offered and the ... determined. CytomX intends to list its common stock under ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Tobramycin Market, 2015-2019 2China Latanoprost Market Investigation Report 2015-2019 2
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
10 L, Bulk Recommended for 5 & 10 L pipettes. Ideal for pipetting into long, narrow tubes or deep well plates....
This extended 10 ul combats contamination by keeping your pipettor out of 1.5 ul and 2.0 ul tubes. Utilizes MicroPoint design and 2 ul reference mark....
... The MonoPrep LBP Processor is a primary ... specimen collection, accessioning, processing, sampling, and slide ... data management. The MonoPrep LBP Processor produces ... from a broad range of cytology specimen ...
Medicine Products: